Dear John,

Join Health Affairs on September 29 for an exclusive Insider virtual event exploring prior authorization. Speakers include A. Mark Fendrick, Ravi Gupta, Michael Anne Kyle, and Christina Andrews.

Sign up to become an Insider for $180/yr.

This week, Eli Lilly’s new GLP-1 pill outperformed Novo’s in a diabetes trial, lowering blood sugar and weight.

For Flashback Friday, let's turn back time and see what Health Affairs has published on the topic of GLP-1 pharmaceuticals.

Health Benefits In 2024: Higher Premiums Persist, Employer Strategies For GLP-1 Coverage And Family-Building Benefits

Gary Claxton et al. (October 2024)

Expanding Medicare Coverage Of Anti-Obesity Medicines Could Increase Annual Spending By $3.1 Billion To $6.1 Billion

Benedic Ippolito and Joseph F. Levy (August 2024)

New Anti-Obesity Medications Should Be Considered Preventive Health Care

William Walters and Richard Hughes IV (July 2024)

To Promote Health And Health Equity, Include Quality Nutrition Care As Part Of Anti-Obesity Medication Therapy

Bob Blancato et al. (May 2024)

Today's Featured Articles

An ACA Supreme Court Case May Have Created an HHS Power Paradox w/ Carmel Shachar

Health Affairs' Jeff Byers welcomes Carmel Shachar of Harvard Law School to the pod to discuss a recent Forefront article she co-authored that  broke down the Kennedy v. Braidwood Management case focusing on access to preventive care and the Supreme Court's framing of the relationship between the HHS Secretary and advisory bodies.

Medicare Coverage Of Intensive Outpatient Programs Could Reduce State Behavioral Health Care Costs

Gretchen Bell and Andrew Spicer

part of our Medicare and Medicaid Integration series

Could Agentic AI Improve Access To Maternal Health Care?

Susannah Baruch and Backtosch Mustafa